{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1383670319309595136.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Hector F. Escobar-Morreale"}],"foaf:familyName":[{"@value":"Escobar-Morreale"}],"foaf:givenName":[{"@value":"Hector F."}]}],"career":[{"institution":{"notation":[{"@value":"Hospital Ramon y Cajal and University of Alcalá (H.F.E.-M.), 28801 Madrid, Spain"}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1363670319309595264","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1210/jc.2006-0178"},{"@type":"URI","@value":"http://academic.oup.com/jcem/article-pdf/91/11/4237/9060002/jcem4237.pdf"}],"notation":[{"@value":"Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1210/jc.2006-0178_7SsN107SGPodv6AAKvIWDXZMCax"}]}